B. Metzler seel. Sohn & Co’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
B. Metzler seel. Sohn & Co's ELV Position: Q2 2026 in Review
B. Metzler seel. Sohn & Co increased its Elevance Health (ELV) stake by 34% in Q2 2026, buying an estimated $2.92M and bringing the position to 31,408 shares worth $12.1M. The position accounts for 0.1% of the portfolio, ranked #107.
B. Metzler seel. Sohn & Co first reported a position in ELV in Q4 2020 and has held it in 23 quarters since. The position peaked at $21.4M in Q4 2020. 1,611 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- B. Metzler seel. Sohn & Co held 31,408 shares of Elevance Health worth $12.1M as of Q2 2026.
- B. Metzler seel. Sohn & Co bought 7,883 Elevance Health shares in Q2 2026, an estimated $2.92M.
- Elevance Health made up 0.1% of B. Metzler seel. Sohn & Co's portfolio in Q2 2026, its #107 holding.
- B. Metzler seel. Sohn & Co first reported a position in Elevance Health in Q4 2020 and has held it in 23 quarters since.
- B. Metzler seel. Sohn & Co's Elevance Health position peaked at $21.4M in Q4 2020.
- 1,611 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on B. Metzler seel. Sohn & Co's 13F filing for Q2 2026, filed 11 Aug 2026.